Skip to content
Disclosery

22NW, LP

Follow

13F filer, CIK 1694297, SEATTLE, WA

22NW, LP reported $104,683,608 across 14 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 94.62% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-26-010406

Period
2026-06-30
Reported value
$105M
Holdings
14
Top 10 weight
94.62%
New
1
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CMTadded+50,783$1.2M
TBCHnew+14,430$180K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FSTRexited-1,067,186-$29.8M
MLYSreduced-330,485-$8.92M
FARMexited-1,955,526-$2.48M
PFXexited-43,115-$1.68M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001214659-26-010406, largest first. % of portfolio is the value over $104,683,608, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NSPINSPERITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 96,300 shares; 2026Q1: 493,000 shares; 2026Q2: 493,000 shares 493,000$20.4M19.45%0Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 146,115 shares; 2025Q3: 331,115 shares; 2025Q4: 331,115 shares; 2026Q1: 281,115 shares; 2026Q2: 281,115 shares 281,115$19.6M18.75%0Timeline
SRISTONERIDGE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 342,787 shares; 2025Q1: 1,627,653 shares; 2025Q2: 1,943,508 shares; 2025Q3: 2,105,600 shares; 2025Q4: 2,192,764 shares; 2026Q1: 2,466,975 shares; 2026Q2: 2,466,975 shares 2,466,975$18.1M17.25%0Timeline
FOXFFOX FACTORY HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 678,165 shares; 2026Q2: 678,165 shares 678,165$11.5M10.98%0Timeline
CMTCORE MOLDING TECHNOLOGIES INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 191,222 shares; 2025Q3: 222,738 shares; 2025Q4: 222,738 shares; 2026Q1: 222,738 shares; 2026Q2: 273,521 shares 273,521$6.46M6.17%+50,783Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 668,679 shares; 2025Q2: 923,679 shares; 2025Q3: 923,679 shares; 2025Q4: 923,679 shares; 2026Q1: 492,759 shares; 2026Q2: 492,759 shares 492,759$5.9M5.64%0Timeline
CULPCULP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,594,390 shares; 2024Q4: 1,624,715 shares; 2025Q1: 1,859,061 shares; 2025Q2: 1,859,061 shares; 2025Q3: 1,859,061 shares; 2025Q4: 1,859,061 shares; 2026Q1: 1,859,061 shares; 2026Q2: 1,859,061 shares 1,859,061$5.76M5.51%0Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 820,653 shares; 2025Q4: 820,653 shares; 2026Q1: 820,653 shares; 2026Q2: 820,653 shares 820,653$4.27M4.08%0Timeline
UFIUNIFI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 233,777 shares; 2025Q1: 731,535 shares; 2025Q2: 981,535 shares; 2025Q3: 977,639 shares; 2025Q4: 852,455 shares; 2026Q1: 852,455 shares; 2026Q2: 852,455 shares 852,455$4.05M3.87%0Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 461,344 shares; 2025Q2: 560,042 shares; 2025Q3: 358,325 shares; 2025Q4: 358,325 shares; 2026Q1: 444,325 shares; 2026Q2: 113,840 shares 113,840$3.07M2.93%-330,485Timeline
TISITEAM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 34,835 shares; 2025Q2: 171,090 shares; 2025Q3: 170,187 shares; 2025Q4: 170,187 shares; 2026Q1: 170,187 shares; 2026Q2: 170,187 shares 170,187$2.94M2.81%0Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 636,364 shares; 2025Q2: 636,364 shares; 2025Q3: 636,364 shares; 2025Q4: 636,364 shares; 2026Q1: 636,364 shares; 2026Q2: 636,364 shares 636,364$2.51M2.4%0Timeline
TBCHTURTLE BEACH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 14,430 shares 14,430$180K0.17%newTimeline
LFCRLIFECORE BIOMEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,755,161 shares; 2024Q4: 1,755,161 shares; 2025Q1: 1,755,161 shares; 2025Q2: 264,180 shares; 2025Q3: 1,254 shares; 2025Q4: 1,254 shares; 2026Q1: 1,254 shares; 2026Q2: 1,254 shares 1,254$6.22K0.01%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FSTRFOSTER L B CO1,067,186$29.8Mshares
FARMFARMER BROS CO1,955,526$2.48Mshares
PFXPHENIXFIN CORP43,115$1.68Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-26-010406 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001214659-26-010406 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001214659-26-006481 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001214659-26-001725 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001214659-25-016649 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001214659-25-012016 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001214659-25-007607 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0001214659-25-002859 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001214659-24-019159 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001214659-24-014708 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001214659-24-009336 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001214659-24-002898 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001214659-23-015144 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001214659-23-011293 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001214659-23-007193 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001214659-23-001946 Quarter ended 2022-12-312023-02-10acceptance time not in the bulk data set
13F-HR 0001214659-22-013686 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001214659-22-009998 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001214659-22-006816 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001214659-22-002610 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001214659-21-011591 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001214659-21-008652 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001214659-21-005411 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001214659-21-001667 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0001214659-20-009472 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001214659-20-007168 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001214659-20-004712 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001214659-20-001500 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001214659-19-007207 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001214659-19-005268 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001214659-19-003524 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001214659-19-000907 Quarter ended 2018-12-312019-02-08acceptance time not in the bulk data set
13F-HR 0001214659-18-007009 Quarter ended 2018-09-302018-11-09acceptance time not in the bulk data set
13F-HR 0001214659-18-005376 Quarter ended 2018-06-302018-08-10acceptance time not in the bulk data set
13F-HR 0001214659-18-003713 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001214659-18-001198 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001214659-17-006649 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001214659-17-005035 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001214659-17-003318 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001214659-17-001064 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set